# | Date | Analyst Firm | Upside/Downside | Price Target Change | Rating Change | Current Rating |
---|
Dear FOSL Directors,Fossil is a $1 bill + co., and a solid brand with ample opportunity, one that enjoys high gross margins in ...
Companies Reporting Before The Bell • Sangamo Therapeutics (NASDAQ:SGMO) is likely to report quarterly loss at $0.26 per share...